Clinical trial

Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management

NCT04567225

Study summary

ClinicalTrials.gov

Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Early Glargine Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Late Glargine Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention IV insulin infusion Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention IV fluid and electrolytes replacement Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2020-10-01

PhasePHASE4

Conditions

Diabetic Ketoacidosisverified · MONDO: diabetic ketoacidosis

Type 1 Diabetesverified · MONDO: type 1 diabetes mellitus

Type 2 Diabetesverified · MONDO: type 2 diabetes mellitus

Interventions

Early GlargineDRUG

Late GlargineDRUG

IV insulin infusionOTHER

IV fluid and electrolytes replacementOTHER

Sponsors & collaborators

The Cleveland Cliniclead sponsor

Mapped research locations

ClevelandOhio, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04567225 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.